Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap1.08B
Enterprise Value1.90B
Trailing P/E23.52
Forward P/E46.86
CNMD
(NYSE)CONMED Corporation
$34.79-- (--)
Loading... - Market loading
CONMED (CNMD) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)0.81
Forward Price/Sales0.77
Price/Book (mrq)1.07
Price/FCF (ttm)7.33
Price/OCF (ttm)6.48
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue1.38
EV/Earnings40.40
EV/EBITDA10.77
EV/EBIT16.10
EV/FCF12.60
Stock Price
Current price, 52-week range, and moving averages
Current Price$34.79
1-Day Change0.48%
52-Week High$61.13
52-Week Low$33.21
52-Week Change-40.19%
YTD Change-12.31%
1-Year Change-41.20%
50-Day MA$40.21
200-Day MA$45.72
Avg Volume (30 day)394.89K
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding31.15M
Book Value per Share$33.17
Net Cash per Share$1.29
FCF per Share$4.84
Analyst Price Targets & Consensus
Wall Street analyst ratings and 12-month price targets (90 days)
Price Target$40.50
Target Upside/Downside16.41%
Analyst ConsensusHold
Analyst Count3
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin53.87%
EBITDA Margin (ttm)12.84%
EBIT Margin (ttm)8.59%
Operating Margin (ttm)8.17%
Pretax Margin (ttm)5.17%
Profit Margin (ttm)3.42%
FCF Margin (ttm)10.98%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)4.55%
Return on Assets (ttm)2.02%
Return on Invested Capital (ttm)4.28%
Return on Capital Employed (ttm)5.87%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue1.37B
Gross Profit740.61M
Operating Income112.26M
Pretax Income71.12M
Net Income47.05M
EBITDA176.48M
EBIT118.08M
Diluted EPS$1.52
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow170.69M
Capital Expenditures19.81M
Free Cash Flow150.88M
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth5.18%
Dividend Growth-50.00%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)2.33B
Cash & Securities (mrq)40.82M
Net Cash (mrq)40.10M
Net Cash per Share$1.29
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)834.94M
Working Capital (mrq)357.82M
Total Equity (mrq)1.03B
Book Value per Share$33.17
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)2.14
Quick Ratio (mrq)1.01
Debt/Equity (mrq)0.81
Debt/EBITDA (ttm)4.73
Debt/FCF (ttm)5.53
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$0.40
Dividend Yield1.13%
Payout Ratio (Earnings)26.38%
Payout Ratio (FCF)8.26%
Dividend Growth (YoY)-50.00%
Ex-Dividend DateSep 15, 2025
Pay DateOct 3, 2025
Dividend FrequencyQuarterly
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield4.25%
FCF Yield13.63%
Buyback Yield0.00%
Total Shareholder Yield1.13%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score1.81
Piotroski F-Score5/9
Dividend Score41.42
Fair Value & Intrinsic Value
Lynch fair value, Graham number, and valuation models
Graham Number$33.64
Graham Upside/Downside-5.32%
Frequently Asked Questions About CONMED Statistics
What are the key financial metrics for CNMD?
CONMED Corporation (CNMD) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is CNMD's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether CONMED is overvalued or undervalued.
How do I read CNMD's profitability ratios?
CONMED's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do CNMD's debt ratios indicate?
The financial health section shows CONMED's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is CNMD's dividend analysis?
The dividend section covers CONMED's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.